KRAS Mutations – Non-Small Cell Lung Cancer
Dr. Chadi Nabhan, Chairman of Precision Oncology Alliance™ at Caris Life Sciences® and Dr. Stephen Liu, an oncologist with Medstar Health and an investigator on this study discuss the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 9544/Poster 310: Characterization of KRAS mutations in non-small cell lung cancer (NSCLC).
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Chadi Nabhan joined Caris Life Sciences® in April of 2020 as Chairman of Precision Oncology Alliance™. As chairman, Dr. Nabhan leads a collaborative network of leading cancer centers that demonstrates a commitment to precision medicine. Prior to joining Caris Dr. Nabhan was Chief Medical Officer of Aptitude Health, a global provider of oncology insights. He was also Chief Medical Officer at Cardinal Health Specialty Solutions where he led clinical programs, real-world evidence, HEOR, regulatory, publications and strategic initiatives for key stakeholders. Previously, Dr. Nabhan was an Associate Professor of Medicine, and Medical Director of the Clinical Cancer Center at the University of Chicago where he oversaw the clinical operations of cancer clinics and supervised all aspects of cancer care delivery. He is currently an Adjunct Professor in the Department of Clinical Pharmacy at the University of South Carolina.Dr. Nabhan maintains active medical licenses in five states, has over 300 peer-reviewed articles and abstracts, and has hosted his own award-winning healthcare podcast named “Outspoken Oncology” since February 2019.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
